Average Co-Inventor Count = 4.34
ph-index = 23
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (108 from 651 patents)
2. Incyte Holdings Corporation (6 from 146 patents)
108 patents:
1. 12312331 - Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
2. 12247026 - Heterocyclic compounds as immunomodulators
3. 12247038 - Pyrido[3,2-d]pyrimidine compounds as immunomodulators
4. 12187743 - Heterocyclic compounds as immunomodulators
5. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors
6. 12129267 - Heteroaryl amide compounds as sting activators
7. 12060433 - CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy
8. 12030889 - Imidazopyridazine and imidazopyridine compounds and uses thereof
9. 11999740 - Fused pyrazine derivatives as A2A / A2B inhibitors
10. 11981671 - Bicyclic pyrazolyl amines as CDK2 inhibitors
11. 11958861 - Spirocyclic lactams as JAK2 V617F inhibitors
12. 11919908 - Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
13. 11919904 - Sulfonylamide compounds as CDK2 inhibitors
14. 11912722 - Tricyclic heteroaryl compounds as sting activators
15. 11873304 - Fused pyrimidine derivatives as A2A/A2B inhibitors